-
1
-
-
84884391626
-
Japanese encephalitis: Status of surveillance and immunization in Asia and the Western Pacific, 2012
-
Japanese encephalitis: status of surveillance and immunization in Asia and the Western Pacific, 2012. Wkly Epidemiol Rec 2013; 88(34):357-64
-
(2013)
Wkly Epidemiol Rec
, vol.88
, Issue.34
, pp. 357-364
-
-
-
2
-
-
80053498530
-
Estimated global incidence of Japanese encephalitis: A systematic review
-
Campbell GL, Hills SL, Fischer M, et al. Estimated global incidence of Japanese encephalitis: a systematic review. Bull World Health Organ 2011;89(10):766-74
-
(2011)
Bull World Health Organ
, vol.89
, Issue.10
, pp. 766-774
-
-
Campbell, G.L.1
Hills, S.L.2
Fischer, M.3
-
3
-
-
84856162987
-
Family - Flaviviridae
-
King AM, Adams MJ, Carstens EB, Lefkowitz EJ, editors. Elsevier; London, UK
-
Simmonds P, Becher P, Collett MS, et al. Family - flaviviridae. In: King AM, Adams MJ, Carstens EB, Lefkowitz EJ, editors. Virus taxonomy. Ninth report of the international committee on taxonomy of viruses. Elsevier; London, UK: 2011. p. 1003-20
-
(2011)
Virus Taxonomy. Ninth Report of the International Committee on Taxonomy of Viruses
, pp. 1003-1020
-
-
Simmonds, P.1
Becher, P.2
Collett, M.S.3
-
4
-
-
0037372114
-
Origin and evolution of Japanese encephalitis virus in southeast Asia
-
Solomon T, Ni H, Beasley DW, et al. Origin and evolution of Japanese encephalitis virus in southeast Asia. J Virol 2003;77(5):3091-8
-
(2003)
J Virol
, vol.77
, Issue.5
, pp. 3091-3098
-
-
Solomon, T.1
Ni, H.2
Beasley, D.W.3
-
5
-
-
0034724247
-
Phylogenetic analysis suggests only one serotype of Japanese encephalitis virus
-
Tsarev SA, Sanders ML, Vaughn DW, et al. Phylogenetic analysis suggests only one serotype of Japanese encephalitis virus. Vaccine 2000;18(Suppl 2):36-43
-
(2000)
Vaccine
, vol.18
, pp. 36-43
-
-
Tsarev, S.A.1
Sanders, M.L.2
Vaughn, D.W.3
-
6
-
-
0036116402
-
Japanese encephalitis virus: Ecology and epidemiology
-
Endy TP, Nisalak A. Japanese encephalitis virus: ecology and epidemiology. Curr Top Microbiol Immunol 2002;267:11-48
-
(2002)
Curr Top Microbiol Immunol
, vol.267
, pp. 11-48
-
-
Endy, T.P.1
Nisalak, A.2
-
8
-
-
0035680905
-
The appearance of a second genotype of Japanese encephalitis virus in the Australasian region
-
Pyke AT, Williams DT, Nisbet DJ, et al. The appearance of a second genotype of Japanese encephalitis virus in the Australasian region. Am J Trop Med Hyg 2001;65(6):747-53
-
(2001)
Am J Trop Med Hyg
, vol.65
, Issue.6
, pp. 747-753
-
-
Pyke, A.T.1
Williams, D.T.2
Nisbet, D.J.3
-
9
-
-
2942661866
-
Shift in Japanese encephalitis virus (JEV) genotype circulating in northern Vietnam: Implications for frequent introductions of JEV from southeast Asia to east Asia
-
Nga PT, del Carmen Parquet M, Cuong VD, et al. Shift in Japanese encephalitis virus (JEV) genotype circulating in northern Vietnam: implications for frequent introductions of JEV from southeast Asia to east Asia. J Gen Virol 2004;85(Pt 6):1625-31
-
(2004)
J Gen Virol
, vol.85
, pp. 1625-1631
-
-
Nga, P.T.1
Del Carmen-Parquet, M.2
Cuong, V.D.3
-
10
-
-
55549146124
-
Change in Japanese encephalitis virus distribution, Thailand
-
Nitatpattana N, Dubot-Peres A, Gouilh MA, et al. Change in Japanese encephalitis virus distribution, Thailand. Emerg Infect Dis 2008;14(11):1762-5
-
(2008)
Emerg Infect Dis
, vol.14
, Issue.11
, pp. 1762-1765
-
-
Nitatpattana, N.1
Dubot-Peres, A.2
Gouilh, M.A.3
-
11
-
-
77953355577
-
Molecular epidemiology of Japanese encephalitis virus circulating in South Korea, 1983-2005
-
Yun SM, Cho JE, Ju YR, et al. Molecular epidemiology of Japanese encephalitis virus circulating in South Korea, 1983-2005. Virol J 2010;7:127
-
(2010)
Virol J
, vol.7
, pp. 127
-
-
Yun, S.M.1
Cho, J.E.2
Ju, Y.R.3
-
12
-
-
84897012118
-
Dynamics of the emergence and establishment of a newly dominant genotype of Japanese encephalitis virus throughout Asia
-
Schuh AJ, Ward MJ, Leigh Brown AJ, et al. Dynamics of the emergence and establishment of a newly dominant genotype of Japanese encephalitis virus throughout Asia. J Virol 2014;88(8):4522-32
-
(2014)
J Virol
, vol.88
, Issue.8
, pp. 4522-4532
-
-
Schuh, A.J.1
Ward, M.J.2
Leigh Brown, A.J.3
-
13
-
-
84920517170
-
Molecular epidemiology of Japanese encephalitis virus in mosquitoes in Taiwan during 2005-2012
-
Su CL, Yang CF, Teng HJ, et al. Molecular epidemiology of Japanese encephalitis virus in mosquitoes in Taiwan during 2005-2012. PLoS Negl Trop Dis 2014;8(10):e3122
-
(2014)
PLoS Negl Trop Dis
, vol.8
, Issue.10
, pp. e3122
-
-
Su, C.L.1
Yang, C.F.2
Teng, H.J.3
-
14
-
-
79960942589
-
Genotype v Japanese encephalitis virus is emerging
-
Li MH, Fu SH, Chen WX, et al. Genotype v Japanese encephalitis virus is emerging. PLoS Negl Trop Dis 2011;5(7):e1231
-
(2011)
PLoS Negl Trop Dis
, vol.5
, Issue.7
, pp. e1231
-
-
Li, M.H.1
Fu, S.H.2
Chen, W.X.3
-
15
-
-
80053173339
-
Emergence of Japanese encephalitis virus genotype v in the Republic of Korea
-
Takhampunya R, Kim HC, Tippayachai B, et al. Emergence of Japanese encephalitis virus genotype V in the Republic of Korea. Virol J 2011;8:449
-
(2011)
Virol J
, vol.8
, pp. 449
-
-
Takhampunya, R.1
Kim, H.C.2
Tippayachai, B.3
-
16
-
-
84922511750
-
Detection of Japanese encephalitis virus genotype v in Culex orientalis and Culex pipiens (Diptera: Culicidae) in Korea
-
Kim H, Cha GW, Jeong YE, et al. Detection of Japanese encephalitis virus genotype V in Culex orientalis and Culex pipiens (Diptera: Culicidae) in Korea. PLoS One 2015;10(2):e0116547
-
(2015)
PLoS One
, vol.10
, Issue.2
, pp. e0116547
-
-
Kim, H.1
Cha, G.W.2
Jeong, Y.E.3
-
18
-
-
0036103618
-
Pathogenesis and clinical features of Japanese encephalitis and West Nile virus infections
-
Solomon T, Vaughn DW. Pathogenesis and clinical features of Japanese encephalitis and West Nile virus infections. Curr Top Microbiol Immunol 2002;267:171-94
-
(2002)
Curr Top Microbiol Immunol
, vol.267
, pp. 171-194
-
-
Solomon, T.1
Vaughn, D.W.2
-
19
-
-
74549198630
-
Evidence and rationale for the World Health Organization recommended standards for Japanese encephalitis surveillance
-
Hills S, Dabbagh A, Jacobson J, et al. Evidence and rationale for the World Health Organization recommended standards for Japanese encephalitis surveillance. BMC Infect Dis 2009;9:214
-
(2009)
BMC Infect Dis
, vol.9
, pp. 214
-
-
Hills, S.1
Dabbagh, A.2
Jacobson, J.3
-
21
-
-
49749089318
-
Japanese encephalitis in a Finnish traveler on a two-week holiday in Thailand
-
Lehtinen VA, Huhtamo E, Siikamaki H, et al. Japanese encephalitis in a Finnish traveler on a two-week holiday in Thailand. J Clin Virol 2008;43(1):93-5
-
(2008)
J Clin Virol
, vol.43
, Issue.1
, pp. 93-95
-
-
Lehtinen, V.A.1
Huhtamo, E.2
Siikamaki, H.3
-
22
-
-
65649083413
-
Japanese encephalitis in travelers: Review of cases and seasonal risk
-
Buhl MR, Lindquist L. Japanese encephalitis in travelers: review of cases and seasonal risk. J Travel Med 2009;16(3): 217-19
-
(2009)
J Travel Med
, vol.16
, Issue.3
, pp. 217-219
-
-
Buhl, M.R.1
Lindquist, L.2
-
23
-
-
65649121208
-
Japanese encephalitis: Defining risk incidence for travelers to endemic countries and vaccine prescribing from the UK and Switzerland
-
Hatz C, Werlein J, Mutsch M, et al. Japanese encephalitis: defining risk incidence for travelers to endemic countries and vaccine prescribing from the UK and Switzerland. J Travel Med 2009;16(3):200-3
-
(2009)
J Travel Med
, vol.16
, Issue.3
, pp. 200-203
-
-
Hatz, C.1
Werlein, J.2
Mutsch, M.3
-
24
-
-
77952687751
-
Japanese encephalitis in travelers from non-endemic countries, 1973-2008
-
Hills SL, Griggs AC, Fischer M. Japanese encephalitis in travelers from non-endemic countries, 1973-2008. Am J Trop Med Hyg 2010;82(5):930-6
-
(2010)
Am J Trop Med Hyg
, vol.82
, Issue.5
, pp. 930-936
-
-
Hills, S.L.1
Griggs, A.C.2
Fischer, M.3
-
25
-
-
84890346940
-
Japanese encephalitis vaccines
-
Plotkin SA, Orenstein WA, Offit PA, editors. 6th edition. Saunders Elsevier
-
Halstead SB, Jacobson J, Dubischar-Kastner K. Japanese encephalitis vaccines. In: Plotkin SA, Orenstein WA, Offit PA, editors. Vaccines. 6th edition. Saunders Elsevier; 2012. p. 312-51
-
(2012)
Vaccines
, pp. 312-351
-
-
Halstead, S.B.1
Jacobson, J.2
Dubischar-Kastner, K.3
-
26
-
-
79952672355
-
Japanese encephalitis in two children-United States, 2010
-
Centers for Disease Control and Prevention (CDC). Japanese encephalitis in two children-United States, 2010. MMWR Morb Mortal Wkly Rep 2011;60(9):276-8
-
(2011)
MMWR Morb Mortal Wkly Rep
, vol.60
, Issue.9
, pp. 276-278
-
-
-
27
-
-
80054894141
-
Japanese encephalitis in a Danish short-term traveler to Cambodia
-
Werlinrud AM, Christiansen CB, Koch A. Japanese encephalitis in a Danish short-term traveler to Cambodia. J Travel Med 2011; 18(6):411-13
-
(2011)
J Travel Med
, vol.18
, Issue.6
, pp. 411-413
-
-
Werlinrud, A.M.1
Christiansen, C.B.2
Koch, A.3
-
28
-
-
79959386976
-
A case of aseptic meningitis due to Japanese encephalitis virus in a traveller returning from the Philippines
-
Jeurissen A, Strauven T. A case of aseptic meningitis due to Japanese encephalitis virus in a traveller returning from the Philippines. Acta Neurol Belg 2011;111(2):143-5
-
(2011)
Acta Neurol Belg
, vol.111
, Issue.2
, pp. 143-145
-
-
Jeurissen, A.1
Strauven, T.2
-
29
-
-
84860365727
-
Epidemiology of Japanese encephalitis in South Korea, 2007-2010
-
Lee DW, Choe YJ, Kim JH, et al. Epidemiology of Japanese encephalitis in South Korea, 2007-2010. Int J Infect Dis 2012;16(6):e448-52
-
(2012)
Int J Infect Dis
, vol.16
, Issue.6
, pp. e448-e452
-
-
Lee, D.W.1
Choe, Y.J.2
Kim, J.H.3
-
30
-
-
84861672778
-
Two laboratory-confirmed cases of Japanese encephalitis imported to Germany by travelers returning from Southeast Asia
-
Tappe D, Nemecek A, Zipp F, et al. Two laboratory-confirmed cases of Japanese encephalitis imported to Germany by travelers returning from Southeast Asia. J Clin Virol 2012;54(3):282-5
-
(2012)
J Clin Virol
, vol.54
, Issue.3
, pp. 282-285
-
-
Tappe, D.1
Nemecek, A.2
Zipp, F.3
-
31
-
-
84883406592
-
A case of Japanese encephalitis in a 20 year-old Spanish sportsman, February 2013
-
Doti P, Castro P, Martinez MJ, et al. A case of Japanese encephalitis in a 20 year-old Spanish sportsman, February 2013. Euro Surveill 2013;18(35):20573
-
(2013)
Euro Surveill
, vol.18
, Issue.35
, pp. 20573
-
-
Doti, P.1
Castro, P.2
Martinez, M.J.3
-
32
-
-
84896729486
-
Japanese encephalitis in a French traveler to Nepal
-
Lagarde S, Lagier JC, Charrel R, et al. Japanese encephalitis in a French traveler to Nepal. J Neurovirol 2014;20(1):99-102
-
(2014)
J Neurovirol
, vol.20
, Issue.1
, pp. 99-102
-
-
Lagarde, S.1
Lagier, J.C.2
Charrel, R.3
-
33
-
-
84906718703
-
A case series of three US adults with Japanese encephalitis, 2010-2012
-
Hills SL, Stoltey J, Martinez D, et al. A case series of three US adults with Japanese encephalitis, 2010-2012. J Travel Med 2014;21(5):310-13
-
(2014)
J Travel Med
, vol.21
, Issue.5
, pp. 310-313
-
-
Hills, S.L.1
Stoltey, J.2
Martinez, D.3
-
34
-
-
84858441158
-
A case of Japanese encephalitis virus infection acquired during a trip in Thailand
-
Langevin S, Libman M, Drebot MA, et al. A case of Japanese encephalitis virus infection acquired during a trip in Thailand. J Travel Med 2012;19(2):127-9
-
(2012)
J Travel Med
, vol.19
, Issue.2
, pp. 127-129
-
-
Langevin, S.1
Libman, M.2
Drebot, M.A.3
-
35
-
-
84929512719
-
Japanese Encephalitis Vaccines: WHO position paper - February 2015
-
Japanese Encephalitis Vaccines: WHO position paper - February 2015. Wkly Epidemiol Rec 2015;90(9):69-87
-
(2015)
Wkly Epidemiol Rec
, vol.90
, Issue.9
, pp. 69-87
-
-
-
37
-
-
84887586601
-
Use of Japanese encephalitis vaccine in children: Recommendations of the advisory committee on immunization practices 2013
-
Centers for Disease Control and Prevention (CDC). Use of Japanese encephalitis vaccine in children: recommendations of the advisory committee on immunization practices 2013. MMWR Morb Mortal Wkly Rep 2013;62(45):898-900
-
(2013)
MMWR Morb Mortal Wkly Rep
, vol.62
, Issue.45
, pp. 898-900
-
-
-
38
-
-
84939440886
-
-
[Last accessed 28 May]
-
Background paper on JE Vaccines-SAGE working group. Available from: www.who. int/immunization/sage/meetings/2014/october/1-JE-Vaccine-Background-Paper.pdf?ua=1 [Last accessed 28 May 2015]
-
(2015)
Background Paper on JE Vaccines-SAGE Working Group
-
-
-
39
-
-
78649502687
-
IMOJEV((R)): A Yellow fever virus-based novel Japanese encephalitis vaccine
-
Appaiahgari MB, Vrati S. IMOJEV((R)): a Yellow fever virus-based novel Japanese encephalitis vaccine. Expert Rev Vaccines 2010;9(12):1371-84
-
(2010)
Expert Rev Vaccines
, vol.9
, Issue.12
, pp. 1371-1384
-
-
Appaiahgari, M.B.1
Vrati, S.2
-
40
-
-
0024264599
-
Japanese encephalitis virus live-attenuated vaccine, Chinese strain SA14-14-2; Adaptation to primary canine kidney cell cultures and preparation of a vaccine for human use
-
Eckels KH, Yu YX, Dubois DR, et al. Japanese encephalitis virus live-attenuated vaccine, Chinese strain SA14-14-2; adaptation to primary canine kidney cell cultures and preparation of a vaccine for human use. Vaccine 1988;6(6):513-18
-
(1988)
Vaccine
, vol.6
, Issue.6
, pp. 513-518
-
-
Eckels, K.H.1
Yu, Y.X.2
Dubois, D.R.3
-
41
-
-
0035860006
-
A purified inactivated Japanese encephalitis virus vaccine made in Vero cells
-
Srivastava AK, Putnak JR, Lee SH, et al. A purified inactivated Japanese encephalitis virus vaccine made in Vero cells. Vaccine 2001;19(31):4557-65
-
(2001)
Vaccine
, vol.19
, Issue.31
, pp. 4557-4565
-
-
Srivastava, A.K.1
Putnak, J.R.2
Lee, S.H.3
-
43
-
-
84993312701
-
-
Annex 1: Summary of Product Characteristics. [Last accessed 28 May]
-
European Medicines Agency. Ixiaro: EPAR - product information. Annex 1: Summary of Product Characteristics. Available from: www.ema.europa.eu/docs/en-GB/document-library/EPAR-Product-Information/human/000963/WC500037287.pdf [Last accessed 28 May 2015]
-
(2015)
Ixiaro: EPAR - Product Information
-
-
-
44
-
-
84939441846
-
-
(Human) (Purified inactivated vaccine-adsorbed) JEEV. WHO [Last accessed 28 May 2015]
-
World Health Organization. Public assessment summary report update-Japanese encephalitis vaccine (Human) (Purified inactivated vaccine-adsorbed) JEEV. WHO 2014. Available from: http://www.who.int/immunization-standards/vaccine-quality/pq-266-je-1dose-biologicale-updated-vpsar.pdf?ua=1 [Last accessed 28 May 2015]
-
(2014)
Public Assessment Summary Report Update-Japanese Encephalitis Vaccine
-
-
-
45
-
-
84939426648
-
Recommendations for inactivated Japanese encephalitis vaccine for human use
-
WHO Technical Report Series, No. 963, Annex 1. [Last accessed 28 May 2015]
-
World Health Organization. Recommendations for inactivated Japanese encephalitis vaccine for human use. In: WHO expert committee on biological standardization, fifty-eight report. WHO Technical Report Series, No. 963, Annex 1 2011. Available from: http://apps.who.int/medicinedocs/documents/s19541en/s19541en.pdf [Last accessed 28 May 2015]
-
(2011)
WHO Expert Committee on Biological Standardization, Fifty-eight Report
-
-
-
46
-
-
26644464588
-
Report on a WHO consultation on immunological endpoints for evaluation of new Japanese encephalitis vaccines, WHO, Geneva, 2-3 September, 2004
-
Hombach J, Solomon T, Kurane I, et al. Report on a WHO consultation on immunological endpoints for evaluation of new Japanese encephalitis vaccines, WHO, Geneva, 2-3 September, 2004. Vaccine 2005;23(45):5205-11
-
(2005)
Vaccine
, vol.23
, Issue.45
, pp. 5205-5211
-
-
Hombach, J.1
Solomon, T.2
Kurane, I.3
-
47
-
-
79960744859
-
Correlation of protection against Japanese encephalitis virus and JE vaccine (IXIARO ((R))) induced neutralizing antibody titers
-
Van Gessel Y, Klade CS, Putnak R, et al. Correlation of protection against Japanese encephalitis virus and JE vaccine (IXIARO ((R))) induced neutralizing antibody titers. Vaccine 2011;29(35):5925-31
-
(2011)
Vaccine
, vol.29
, Issue.35
, pp. 5925-5931
-
-
Van Gessel, Y.1
Klade, C.S.2
Putnak, R.3
-
48
-
-
34047107914
-
A Phase 2 study of a purified, inactivated virus vaccine to prevent Japanese encephalitis
-
Lyons A, Kanesa-thasan N, Kuschner RA, et al. A Phase 2 study of a purified, inactivated virus vaccine to prevent Japanese encephalitis. Vaccine 2007;25(17):3445-53
-
(2007)
Vaccine
, vol.25
, Issue.17
, pp. 3445-3453
-
-
Lyons, A.1
Kanesa-Thasan, N.2
Kuschner, R.A.3
-
49
-
-
36549069631
-
Safety and immunogenicity of a Vero-cellderived, inactivated Japanese encephalitis vaccine: A non-inferiority, phase III, randomised controlled trial
-
Tauber E, Kollaritsch H, Korinek M, et al. Safety and immunogenicity of a Vero-cellderived, inactivated Japanese encephalitis vaccine: a non-inferiority, phase III, randomised controlled trial. Lancet 2007; 370(9602):1847-53
-
(2007)
Lancet
, vol.370
, Issue.9602
, pp. 1847-1853
-
-
Tauber, E.1
Kollaritsch, H.2
Korinek, M.3
-
50
-
-
61549095001
-
Comparison of a single, high-dose vaccination regimen to the standard regimen for the investigational Japanese encephalitis vaccine, IC51: A randomized, observer-blind, controlled Phase 3 study
-
Schuller E, Klade CS, Wolfl G, et al. Comparison of a single, high-dose vaccination regimen to the standard regimen for the investigational Japanese encephalitis vaccine, IC51: a randomized, observer-blind, controlled Phase 3 study. Vaccine 2009;27(15):2188-93
-
(2009)
Vaccine
, vol.27
, Issue.15
, pp. 2188-2193
-
-
Schuller, E.1
Klade, C.S.2
Wolfl, G.3
-
51
-
-
67649365435
-
Safety and immunogenicity of concomitant vaccination with the cell-culture based Japanese Encephalitis vaccine IC51 and the hepatitis A vaccine HAVRIX1440 in healthy subjects: A single-blind, randomized, controlled Phase 3 study
-
Kaltenbock A, Dubischar-Kastner K, Eder G, et al. Safety and immunogenicity of concomitant vaccination with the cell-culture based Japanese Encephalitis vaccine IC51 and the hepatitis A vaccine HAVRIX1440 in healthy subjects: A single-blind, randomized, controlled Phase 3 study. Vaccine 2009;27(33):4483-9
-
(2009)
Vaccine
, vol.27
, Issue.33
, pp. 4483-4489
-
-
Kaltenbock, A.1
Dubischar-Kastner, K.2
Eder, G.3
-
53
-
-
84939429399
-
-
Procedure No. EMEA/H/C/000963. [Last accessed 28 May 2015]
-
EMA. Assessment report for Ixiaro. Procedure No. EMEA/H/C/000963 2009. Available from: http://www.ema.europa.eu/docs/en-GB/document-library/EPAR-Public-assessment-report/human/000963/WC500037286.pdf [Last accessed 28 May 2015]
-
(2009)
Assessment Report for Ixiaro
-
-
EMA1
-
54
-
-
84859423409
-
Immunogenicity of one dose of Vero cell culture-derived Japanese encephalitis (JE) vaccine in adults previously vaccinated with mouse brain-derived JE vaccine
-
Woolpert T, Staples JE, Faix DJ, et al. Immunogenicity of one dose of Vero cell culture-derived Japanese encephalitis (JE) vaccine in adults previously vaccinated with mouse brain-derived JE vaccine. Vaccine 2012;30(20):3090-6
-
(2012)
Vaccine
, vol.30
, Issue.20
, pp. 3090-3096
-
-
Woolpert, T.1
Staples, J.E.2
Faix, D.J.3
-
55
-
-
84865475058
-
A single dose of vero cell-derived Japanese encephalitis (JE) vaccine (Ixiaro) effectively boosts immunity in travelers primed with mouse brain-derived JE vaccines
-
Erra EO, Askling HH, Rombo L, et al. A single dose of vero cell-derived Japanese encephalitis (JE) vaccine (Ixiaro) effectively boosts immunity in travelers primed with mouse brain-derived JE vaccines. Clin Infect Dis 2012;55(6):825-34
-
(2012)
Clin Infect Dis
, vol.55
, Issue.6
, pp. 825-834
-
-
Erra, E.O.1
Askling, H.H.2
Rombo, L.3
-
56
-
-
84871798025
-
Cross-protective capacity of Japanese encephalitis (JE) vaccines against circulating heterologous JE virus genotypes
-
Erra EO, Askling HH, Yoksan S, et al. Cross-protective capacity of Japanese encephalitis (JE) vaccines against circulating heterologous JE virus genotypes. Clin Infect Dis 2013;56(2):267-70
-
(2013)
Clin Infect Dis
, vol.56
, Issue.2
, pp. 267-270
-
-
Erra, E.O.1
Askling, H.H.2
Yoksan, S.3
-
57
-
-
84908158054
-
Co-administration of a meningococcal glycoconjugate ACWY vaccine with travel vaccines: A randomized, open-label, multi-center study
-
Alberer M, Burchard G, Jelinek T, et al. Co-administration of a meningococcal glycoconjugate ACWY vaccine with travel vaccines: a randomized, open-label, multi-center study. Travel Med Infect Dis 2014;12(5):485-93
-
(2014)
Travel Med Infect Dis
, vol.12
, Issue.5
, pp. 485-493
-
-
Alberer, M.1
Burchard, G.2
Jelinek, T.3
-
58
-
-
84934833289
-
Short-term immunogenicity and safety of an accelerated pre-exposure prophylaxis regimen with Japanese encephalitis vaccine in combination with a rabies vaccine: A Phase III, multicenter, observer-blind study
-
[Epub ahead of print]
-
Jelinek T, Burchard GD, Dieckmann S, et al. Short-term immunogenicity and safety of an accelerated pre-exposure prophylaxis regimen with Japanese encephalitis vaccine in combination with a rabies vaccine: a Phase III, multicenter, observer-blind study. J Travel Med 2015. [Epub ahead of print]
-
(2015)
J Travel Med
-
-
Jelinek, T.1
Burchard, G.D.2
Dieckmann, S.3
-
59
-
-
84939452257
-
-
Procedure No.: EMEA/H/C/000963/II/0039/G. [Last accessed 28 May 2015]
-
EMA. Assessment report. Ixiaro. Procedure No.: EMEA/H/C/000963/II/0039/G. 2013. Available from: www.ema.europa.eu/docs/en-GB/document-library/EPAR-Assessment-Report-Variation/human/000963/WC500142252.pdf [Last accessed 28 May 2015]
-
(2013)
Assessment Report. Ixiaro
-
-
EMA1
-
60
-
-
78650416836
-
Safety and immunogenicity of a single administration of live-attenuated Japanese encephalitis vaccine in previously primed 2- to 5-year-olds and naive 12- to 24-month-olds: Multicenter randomized controlled trial
-
Chokephaibulkit K, Sirivichayakul C, Thisyakorn U, et al. Safety and immunogenicity of a single administration of live-attenuated Japanese encephalitis vaccine in previously primed 2- to 5-year-olds and naive 12- to 24-month-olds: multicenter randomized controlled trial. Pediatr Infect Dis J 2010;29(12):1111-17
-
(2010)
Pediatr Infect Dis J
, vol.29
, Issue.12
, pp. 1111-1117
-
-
Chokephaibulkit, K.1
Sirivichayakul, C.2
Thisyakorn, U.3
-
61
-
-
84939459497
-
A Japanese encephalitis vaccine from India induces durable and cross-protective immunity against temporally and spatially wide-ranging global field strains
-
[Epub ahead of print]
-
Singh A, Mitra M, Sampath G, et al. A Japanese encephalitis vaccine from India induces durable and cross-protective immunity against temporally and spatially wide-ranging global field strains. J Infect Dis 2015. [Epub ahead of print]
-
(2015)
J Infect Dis
-
-
Singh, A.1
Mitra, M.2
Sampath, G.3
-
62
-
-
84939459770
-
Accelerated 1-week vaccination regimens for rabies pre-exposure and Japanese encephalitis prophylaxis
-
24-28 May, Québec City, Canada
-
Jelinek T, Cramer J, Burchard G, et al. Accelerated 1-week vaccination regimens for rabies pre-exposure and Japanese encephalitis prophylaxis. Presented at The 14th Conference of the International Society of Travel Medicine. 24-28 May 2015, Québec City, Canada
-
(2015)
Presented at the 14th Conference of the International Society of Travel Medicine
-
-
Jelinek, T.1
Cramer, J.2
Burchard, G.3
-
63
-
-
77954959942
-
Long-term immunity and immune response to a booster dose following vaccination with the inactivated Japanese encephalitis vaccine IXIARO, IC51
-
Dubischar-Kastner K, Eder S, Buerger V, et al. Long-term immunity and immune response to a booster dose following vaccination with the inactivated Japanese encephalitis vaccine IXIARO, IC51. Vaccine 2010;28(32):5197-202
-
(2010)
Vaccine
, vol.28
, Issue.32
, pp. 5197-5202
-
-
Dubischar-Kastner, K.1
Eder, S.2
Buerger, V.3
-
64
-
-
47849106825
-
Long-term immunogenicity of the new Vero cell-derived, inactivated Japanese encephalitis virus vaccine IC51 Six and 12 month results of a multicenter follow-up phase 3 study
-
Schuller E, Jilma B, Voicu V, et al. Long-term immunogenicity of the new Vero cell-derived, inactivated Japanese encephalitis virus vaccine IC51 Six and 12 month results of a multicenter follow-up phase 3 study. Vaccine 2008;26(34):4382-6
-
(2008)
Vaccine
, vol.26
, Issue.34
, pp. 4382-4386
-
-
Schuller, E.1
Jilma, B.2
Voicu, V.3
-
65
-
-
79952248906
-
Long term immunity following a booster dose of the inactivated Japanese Encephalitis vaccine IXIARO(R), IC51
-
Eder S, Dubischar-Kastner K, Firbas C, et al. Long term immunity following a booster dose of the inactivated Japanese Encephalitis vaccine IXIARO(R), IC51. Vaccine 2011;29(14):2607-12
-
(2011)
Vaccine
, vol.29
, Issue.14
, pp. 2607-2612
-
-
Eder, S.1
Dubischar-Kastner, K.2
Firbas, C.3
-
66
-
-
79958287508
-
Recommendations for use of a booster dose of inactivated vero cell culture-derived Japanese encephalitis vaccine: Advisory committee on immunization practices, 2011. MMWR Morb
-
Centers for Disease Control and Prevention (CDC). Recommendations for use of a booster dose of inactivated vero cell culture-derived Japanese encephalitis vaccine: advisory committee on immunization practices, 2011. MMWR Morb. Mortal Wkly Rep 2011;60(20):661-3
-
(2011)
Mortal Wkly Rep
, vol.60
, Issue.20
, pp. 661-663
-
-
-
67
-
-
84891935899
-
Cross-protection elicited by primary and booster vaccinations against Japanese encephalitis: A two-year follow-up study
-
Erra EO, Askling HH, Yoksan S, et al. Cross-protection elicited by primary and booster vaccinations against Japanese encephalitis: a two-year follow-up study. Vaccine 2013;32(1):119-23
-
(2013)
Vaccine
, vol.32
, Issue.1
, pp. 119-123
-
-
Erra, E.O.1
Askling, H.H.2
Yoksan, S.3
-
69
-
-
0014907356
-
A field trial with an improved Japanese encephalitis vaccine in a nonendemic area of the disease
-
Kanamitsu M, Hashimoto N, Urasawa S, et al. A field trial with an improved Japanese encephalitis vaccine in a nonendemic area of the disease. Biken J 1970;13(4):313-28
-
(1970)
Biken J
, vol.13
, Issue.4
, pp. 313-328
-
-
Kanamitsu, M.1
Hashimoto, N.2
Urasawa, S.3
-
70
-
-
0344758398
-
Primary and booster immune responses to SA14-14-2 Japanese encephalitis vaccine in Korean infants
-
Sohn YM, Park MS, Rho HO, et al. Primary and booster immune responses to SA14-14-2 Japanese encephalitis vaccine in Korean infants. Vaccine 1999;17(18): 2259-64
-
(1999)
Vaccine
, vol.17
, Issue.18
, pp. 2259-2264
-
-
Sohn, Y.M.1
Park, M.S.2
Rho, H.O.3
-
71
-
-
84903733790
-
Immunogenicity of single-dose Vero cell-derived Japanese encephalitis vaccine in Japanese adults
-
Takeshita N, Lim CK, Mizuno Y, et al. Immunogenicity of single-dose Vero cell-derived Japanese encephalitis vaccine in Japanese adults. J Infect Chemother 2014; 20(4):238-42
-
(2014)
J Infect Chemother
, vol.20
, Issue.4
, pp. 238-242
-
-
Takeshita, N.1
Lim, C.K.2
Mizuno, Y.3
-
74
-
-
84954358400
-
Effect of pre-existing anti-tick-borne encephalitis virus immunity on neutralising antibody response to the Vero cell-derived, inactivated Japanese encephalitis virus vaccine candidate IC51
-
Schuller E, Klade CS, Heinz FX, et al. Effect of pre-existing anti-tick-borne encephalitis virus immunity on neutralising antibody response to the Vero cell-derived, inactivated Japanese encephalitis virus vaccine candidate IC51. Vaccine 2008; 26(48):6151-6
-
(2008)
Vaccine
, vol.26
, Issue.48
, pp. 6151-6156
-
-
Schuller, E.1
Klade, C.S.2
Heinz, F.X.3
-
75
-
-
84887807251
-
Immunogenicity and safety of the inactivated Japanese encephalitis vaccine Ixiaro, IC51, in elderly
-
19-23 May, Maastricht, The Netherlands
-
Dubischar-Kastner K, Cramer J, Eder S, et al. Immunogenicity and safety of the inactivated Japanese encephalitis vaccine Ixiaro, IC51, in elderly. Presented at The 13th Conference of the International Society of Travel Medicine. 19-23 May 2013, Maastricht, The Netherlands
-
(2013)
Presented at the 13th Conference of the International Society of Travel Medicine
-
-
Dubischar-Kastner, K.1
Cramer, J.2
Eder, S.3
-
76
-
-
67649393351
-
Vaccination in the elderly: An immunological perspective
-
Chen WH, Kozlovsky BF, Effros RB, et al. Vaccination in the elderly: an immunological perspective. Trends Immunol 2009;30(7):351-9
-
(2009)
Trends Immunol
, vol.30
, Issue.7
, pp. 351-359
-
-
Chen, W.H.1
Kozlovsky, B.F.2
Effros, R.B.3
-
77
-
-
71349087878
-
Immunogenicity and safety of IXIARO (IC51) in a Phase II study in healthy Indian children between 1 and 3 years of age
-
Kaltenbock A, Dubischar-Kastner K, Schuller E, et al. Immunogenicity and safety of IXIARO (IC51) in a Phase II study in healthy Indian children between 1 and 3 years of age. Vaccine 2010;28(3):834-9
-
(2010)
Vaccine
, vol.28
, Issue.3
, pp. 834-839
-
-
Kaltenbock, A.1
Dubischar-Kastner, K.2
Schuller, E.3
-
78
-
-
84939421407
-
-
STN 125280/125. (Clinical reviewer: Fink, DL.). [Last accessed 28 May 2015]
-
FDA. Clinical review - Ixiaro. STN 125280/125. (Clinical reviewer: Fink, DL.) 2013. Available from: www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM354012.pdf [Last accessed 28 May 2015]
-
(2013)
Clinical Review - Ixiaro
-
-
FDA1
-
79
-
-
84939418860
-
24-months antibody persistence in children with and without a booster dose of an inactivated Japanese encephalitis vaccine, JE-VC, IC51
-
5-8 June, Bergen, Norway
-
Dubischar-Kastner K, Kadlecek V, Bézay N, et al. 24-Months antibody persistence in children with and without a booster dose of an inactivated Japanese encephalitis vaccine, JE-VC, IC51. Presented at The 5th Northern European Conference on Travel Medicine. 5-8 June 2014, Bergen, Norway
-
(2014)
Presented at the 5th Northern European Conference on Travel Medicine
-
-
Dubischar-Kastner, K.1
Kadlecek, V.2
Bézay, N.3
-
80
-
-
84939452825
-
Safety and immunogenicity data for inactivated Japanese encephalitis vaccine (JEVC), IC51, in children from je non-endemic countries
-
5-8 June, Bergen, Norway
-
Dubischar-Kastner K, Ayad A, Cramer J, et al. Safety and immunogenicity data for inactivated Japanese encephalitis vaccine (JEVC), IC51, in children from je non-endemic countries. Presented at The 5th Northern European Conference on Travel Medicine. 5-8 June 2014, Bergen, Norway
-
(2014)
Presented at the 5th Northern European Conference on Travel Medicine
-
-
Dubischar-Kastner, K.1
Ayad, A.2
Cramer, J.3
-
81
-
-
84881054008
-
Global advisory committee on vaccine safety,12-13 June 2013
-
Global advisory committee on vaccine safety,12-13 June 2013. Wkly Epidemiol Rec 2013;88(29):301-12
-
(2013)
Wkly Epidemiol Rec
, vol.88
, Issue.29
, pp. 301-312
-
-
-
82
-
-
82455192358
-
Safety profile of the Vero cell-derived Japanese encephalitis virus (JEV) vaccine IXIARO((R))
-
Schuller E, Klingler A, Dubischar-Kastner K, et al. Safety profile of the Vero cell-derived Japanese encephalitis virus (JEV) vaccine IXIARO((R)). Vaccine 2011;29(47):8669-76
-
(2011)
Vaccine
, vol.29
, Issue.47
, pp. 8669-8676
-
-
Schuller, E.1
Klingler, A.2
Dubischar-Kastner, K.3
-
83
-
-
84939419464
-
Post-marketing safety profile of the inactivated Japanese encephalitis vaccine Ixiaro - Experience three years after launch
-
19-23 May, Maastricht, The Netherlands
-
Müller Z, Dubischar-Kastner K, Hennig R, et al. Post-marketing safety profile of the inactivated Japanese encephalitis vaccine Ixiaro - experience three years after launch. Presented at The 13th Conference of the International Society of Travel Medicine. 19-23 May 2013, Maastricht, The Netherlands
-
(2013)
Presented at the 13th Conference of the International Society of Travel Medicine
-
-
Müller, Z.1
Dubischar-Kastner, K.2
Hennig, R.3
-
84
-
-
84921281365
-
Adverse events following vaccination with an inactivated, Vero cell culture-derived Japanese encephalitis vaccine in the United States, 2009-2012
-
Rabe IB, Miller ER, Fischer M, et al. Adverse events following vaccination with an inactivated, Vero cell culture-derived Japanese encephalitis vaccine in the United States, 2009-2012. Vaccine 2015;33(5): 708-12
-
(2015)
Vaccine
, vol.33
, Issue.5
, pp. 708-712
-
-
Rabe, I.B.1
Miller, E.R.2
Fischer, M.3
-
85
-
-
77956399155
-
Safety analysis of a Vero-cell culture derived Japanese encephalitis vaccine, IXIARO (IC51), in 6 months of follow-up
-
Dubischar-Kastner K, Kaltenboeck A, Klingler A, et al. Safety analysis of a Vero-cell culture derived Japanese encephalitis vaccine, IXIARO (IC51), in 6 months of follow-up. Vaccine 2010; 28(39):6463-9
-
(2010)
Vaccine
, vol.28
, Issue.39
, pp. 6463-6469
-
-
Dubischar-Kastner, K.1
Kaltenboeck, A.2
Klingler, A.3
|